Nur ahmed Khatib

Dr. Nur ahmed Khatib

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
NKNur ahmed Khatib
Nur ahmed Khatib
ETErez Tsumi
Erez Tsumi
ABAmjad Baidousi
Amjad Baidousi
HNHanan Nussinovitch
Hanan Nussinovitch
NBNatalya Bilenko
Natalya Bilenko
JLJaime Levy
Jaime Levy

11 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
NKNur ahmed Khatib
Nur ahmed Khatib
JMJohannes H.M. Merks
Johannes H.M. Merks
JMJeroen E. Markenstein
Jeroen E. Markenstein
BBBrian V. Balgobind
Brian V. Balgobind
CSCemile. D. Savci-Heijink
Cemile. D. Savci-Heijink
PSPeerooz Saeed
Peerooz Saeed
(1) Background: Orbital rhabdomyosarcoma is a rare and aggressive soft tissue tumor that primarily occurs in the eye socket (orbit) of children. Treatment usually involves a combination of surgery, chemotherapy, and radiation therapy, aiming to remove the tumor and prevent metastasis. (2) Methods: An institutional retrospective study was conducted with data from 39 patients with primary orbital RMS treated between 1995 and 2016 at the Amsterdam University Medical Centers/Emma Children Hospital. (3) Results: The median age at presentation was 7 years (range, 9 months to 16 years). The median follow-up period was 9.4 years (range, 3 to 25 years). Ten underwent chemotherapy and excision without additional radiotherapy. A total of 29 patients received additional local treatment: Ablative surgery MOld technique with after loading brachytherapy and surgical REconstruction (AMORE) (N = 21), proton (N = 4) or external beam radiation treatment (EBRT; N = 4). We found 14 cases with recurrences, 9 of which underwent exenteration and two of which died. The 10-year overall survival rate was 95% and the EFS was 63%. (4) Conclusions: long-term follow-up with 10-year survival rate of orbital RMS in this series was 95% achieved by local tumor control and eye preservation in 77% of our study population.